250 related articles for article (PubMed ID: 27236157)
1. Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S
Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
4. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents.
Srijiwangsa P; Ponnikorn S; Na-Bangchang K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):32. PubMed ID: 29914576
[TBL] [Abstract][Full Text] [Related]
5. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.
Intuyod K; Saavedra-García P; Zona S; Lai CF; Jiramongkol Y; Vaeteewoottacharn K; Pairojkul C; Yao S; Yong JS; Trakansuebkul S; Waraasawapati S; Luvira V; Wongkham S; Pinlaor S; Lam EW
Cell Death Dis; 2018 Dec; 9(12):1185. PubMed ID: 30538221
[TBL] [Abstract][Full Text] [Related]
7. Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
Yuan J; Lv H; Peng B; Wang C; Yu Y; He Z
Cancer Chemother Pharmacol; 2009 May; 63(6):1103-10. PubMed ID: 18820913
[TBL] [Abstract][Full Text] [Related]
8. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L
Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
[TBL] [Abstract][Full Text] [Related]
10. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
Hahnvajanawong C; Chaiyagool J; Seubwai W; Bhudhisawasdi V; Namwat N; Khuntikeo N; Sripa B; Pugkhem A; Tassaneeyakul W
World J Gastroenterol; 2012 Aug; 18(30):3955-61. PubMed ID: 22912546
[TBL] [Abstract][Full Text] [Related]
11. Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents.
Zeekpudsa P; Kukongviriyapan V; Senggunprai L; Sripa B; Prawan A
J Exp Clin Cancer Res; 2014 Jan; 33(1):11. PubMed ID: 24460787
[TBL] [Abstract][Full Text] [Related]
12. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of stem cell markers and ABC transporters in 5-fluorouracil resistant Hep-2 cells.
Duz MB; Karatas OF
Mol Biol Rep; 2020 Jul; 47(7):5431-5438. PubMed ID: 32627138
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of ten-eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P-glycoprotein expression.
Wang C; Ye H; Zhang L; Cheng Y; Xu S; Zhang P; Zhang Z; Bai J; Meng F; Zhong L; Shi G; Li H
Cancer Med; 2019 Mar; 8(3):990-1003. PubMed ID: 30784212
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of retinoic acid receptor-β reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis.
Ren HY; Chen B; Huang GL; Liu Y; Shen DY
Mol Med Rep; 2016 Oct; 14(4):3602-8. PubMed ID: 27599527
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer resistance protein expression and 5-fluorouracil resistance.
Yuan JH; Cheng JQ; Jiang LY; Ji WD; Guo LF; Liu JJ; Xu XY; He JS; Wang XM; Zhuang ZX
Biomed Environ Sci; 2008 Aug; 21(4):290-5. PubMed ID: 18837291
[TBL] [Abstract][Full Text] [Related]
18. The Upregulation of OCT4 in Acidic Extracellular pH is Associated with Gemcitabine Resistance in Cholangiocarcinoma Cell Lines.
Choodetwattana P; Proungvitaya S; Jearanaikoon P; Limpaiboon T
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2745-2748. PubMed ID: 31554372
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
[TBL] [Abstract][Full Text] [Related]
20. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma Patients.
Wattanavises S; Silsirivanit A; Sawanyawisuth K; Cha'on U; Waraasawapati S; Saentaweesuk W; Luang S; Chalermwat C; Wongkham C; Wongkham S
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31795149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]